13F-HR filed by Velan Capital Investment Management LP
Velan Capital Investment Management LP filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-14, with 17 holding rows worth $174,552,945.
- Accession
- 0001848809-24-000007
- Filer
- CIK 1848809
- Filed
- 2024-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2024
A holdings report, 18 entries on the cover page, a total value of $174,552,945 stated on the cover page (in dollars after the unit check, H1), rows summing to $174,552,945 with VALUE read as dollars as filed, 13F file number 028-21996. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ALIMERA SCIENCES INC | 016259202 | COM | 13,608,533 | $75,663,443 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871202 | COM NEW | 1,471,904 | $32,547,896 | dollars as filed | |
| HERON THERAPEUTICS INC | 427746102 | COM | 6,986,744 | $24,453,604 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 350,666 | $14,503,546 | dollars as filed | |
| Tourmaline Bio Inc | 89157D105 | Common Stock | 319,080 | $4,103,369 | dollars as filed | |
| TELA BIO INC | 872381108 | COM | 746,087 | $3,506,609 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 800,000 | $3,440,000 | dollars as filed | |
| SKYE BIOSCIENCE INC | 83086J200 | COM NEW | 422,142 | $3,381,357 | dollars as filed | |
| OPTINOSE INC | 68404V100 | COM | 2,492,830 | $2,592,543 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 1,290,323 | $2,587,098 | dollars as filed | |
| INSPIREMD INC | 45779A846 | COM | 904,029 | $2,255,824 | dollars as filed | |
| OUTLOOK THERAPEUTICS INC | 69012T305 | COM | 247,084 | $1,823,480 | dollars as filed | |
| ELEVATION ONCOLOGY INC COM | 28623U101 | Stock | 597,299 | $1,612,707 | dollars as filed | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 480,000 | $998,400 | dollars as filed | |
| KIORA PHARMACEUTICALS INC | 49721T507 | COM | 122,223 | $513,337 | dollars as filed | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 659,020 | $382,232 | dollars as filed | |
| ASLAN PHARMACEUTICALS LTD | 04522R200 | SPON ADS NEW | 625,000 | $187,500 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001848809-24-000007 | this filing | 2024-08-14 | acceptance time not in the bulk data set |